IGFBP6 and non-Hodgkin lymphoma: Among the 37 significant biomarkers in this analysis, four (OC, ApoA1, MMP-9, IGFBP-6) were observed to be decreased in the A-NHL subjects relative to the control groups, while the remaining 33 biomarkers were all increased.